0576-88813233
那拉匹韦Narlaprevir是口服生物相容性的NS3蛋白酶抑制剂,Ki为6 nM,EC90为40 nM。
中文别名:
(1R,2S,5S)-N-[(1S)-1-[(环丙基氨基)氧代乙酰基]戊基]-3-[(2S)-2-[[[[1-[[(叔丁基)磺酰]甲基]环己基]氨基]羰基]氨基]-3,3-二甲基-1-氧代丁基]-6,6-二甲基-3-氮杂双环[3.1.0]己烷-2-甲酰胺
物化属性:
密度:1.21
[1]. Ashok Arasappan, et al. Discovery of Narlaprevir (SCH 900518): A Potent, Second Generation HCV NS3 Serine Protease Inhibitor. ACS Med. Chem. Lett., 2010, 1 (2), pp 64–69
[2]. Tong X, Arasappan A, Bennett F, Chase R, Feld B, Guo Z, Hart A, Madison V, Malcolm B, Pichardo J, Prongay A, Ralston R, Skelton A, Xia E, Zhang R, Njoroge FG.Preclinical characterization of the antiviral activity of SCH 900518 (narlaprevir), a novel mecha
版权所有 Copyright(C) 2018-2024 台州市科瑞生物技术有限公司